3,5-dimethyl-14-[1-[4-phenyl-2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]-12-[3-[1-[4-phenyl-2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]phenoxy]-8,16-dioxa-4,6-diazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),2,4,6,10(15),11,13-heptaene
C70H62N6O3 — CID 176823047
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3,5-dimethyl-14-[1-[4-phenyl-2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]-12-[3-[1-[4-phenyl-2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]phenoxy]-8,16-dioxa-4,6-diazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),2,4,6,10(15),11,13-heptaene
3,5-dimethyl-14-[1-[4-phenyl-2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]-12-[3-[1-[4-phenyl-2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]phenoxy]-8,16-dioxa-4,6-diazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),2,4,6,10(15),11,13-heptaene (PubChem CID 176823047) has the molecular formula C70H62N6O3 and a molecular weight of 1035.30 g/mol. Its IUPAC name is 3,5-dimethyl-14-[1-[4-phenyl-2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]-12-[3-[1-[4-phenyl-2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]phenoxy]-8,16-dioxa-4,6-diazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),2,4,6,10(15),11,13-heptaene.
Molecular Properties
| Compound Name | 3,5-dimethyl-14-[1-[4-phenyl-2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]-12-[3-[1-[4-phenyl-2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]phenoxy]-8,16-dioxa-4,6-diazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),2,4,6,10(15),11,13-heptaene |
|---|---|
| PubChem CID | 176823047 |
| Molecular Formula | C70H62N6O3 |
| Molecular Weight | 1035.30 g/mol |
| Exact Mass | 1034.49 |
| IUPAC Name | 3,5-dimethyl-14-[1-[4-phenyl-2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]-12-[3-[1-[4-phenyl-2,6-di(propan-2-yl)phenyl]benzimidazol-2-yl]phenoxy]-8,16-dioxa-4,6-diazatetracyclo[7.7.0.02,7.010,15]hexadeca-1(9),2,4,6,10(15),11,13-heptaene |
| SMILES | Cc1nc(C)c2c(n1)oc1c3cc(Oc4cccc(-c5nc6ccccc6n5-c5c(C(C)C)cc(-c6ccccc6)cc5C(C)C)c4)cc(-c4nc5ccccc5n4-c4c(C(C)C)cc(-c5ccccc5)cc4C(C)C)c3oc12 |
| InChI | InChI=1S/C70H62N6O3/c1-39(2)52-33-48(45-22-13-11-14-23-45)34-53(40(3)4)63(52)75-60-30-19-17-28-58(60)73-68(75)47-26-21-27-50(32-47)77-51-37-56-65(78-67-62-43(9)71-44(10)72-70(62)79-66(56)67)57(38-51)69-74-59-29-18-20-31-61(59)76(69)64-54(41(5)6)35-49(36-55(64)42(7)8)46-24-15-12-16-25-46/h11-42H,1-10H3 |
| InChIKey | OXZHRVZKKHFWJD-UHFFFAOYSA-N |
| XLogP | 19.37 |
| TPSA | 96.93 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 12 |
| Heavy Atoms | 79 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1035.30 |
| LogP ≤ 5 | 19.37 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 176823047 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.